Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / HLYK - HealthLynked Welcomes David Rosal as New Chief Financial Officer | Benzinga


HLYK - HealthLynked Welcomes David Rosal as New Chief Financial Officer | Benzinga

  • NAPLES, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB:HLYK), a pioneering provider of healthcare network and services, is delighted to announce the appointment of David Rosal as its new Chief Financial Officer (CFO), effective March 18, 2024. With a distinguished career that spans over two decades, Rosal brings a wealth of experience in financial planning, business scaling, and strategic development, notably from his impactful roles at McDonald's Corporation and Teradata.

    During his tenure at McDonald's, Rosal was instrumental in scaling the business through his expertise in financial planning and analysis, business integration, concept development, and due diligence for M&A of major businesses. His leadership significantly contributed to the company's growth and operational efficiency across multiple locations. This experience is directly relevant to HealthLynked's mission to expand its in-network physician and healthcare service network, aiming to transform healthcare into a more connected, efficient, and patient-centric system as well as possible future M&A related to digital healthcare.

    At Teradata, as a Senior Industry Expert in CFO Analytics, Rosal led the way in revolutionizing how data is leveraged, particularly in managing large datasets, working directly with large company CFOs to deliver on their wants and needs. His work is set to be a cornerstone for HealthLynked, especially in managing healthcare data to benefit our patient members by providing insights into better care management and understanding disease-related events. This aligns with HealthLynked's commitment to leveraging technology for the betterment of healthcare delivery and patient outcomes.

    Michael Dent, M.D., CEO of HealthLynked, expressed his enthusiasm for Rosal's appointment, stating, "David's impressive track record in scaling businesses and his ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: HealthLynked Corp
    Stock Symbol: HLYK
    Market: OTC
    Website: healthlynked.com

    Menu

    HLYK HLYK Quote HLYK Short HLYK News HLYK Articles HLYK Message Board
    Get HLYK Alerts

    News, Short Squeeze, Breakout and More Instantly...